vs
Side-by-side financial comparison of SBC Medical Group Holdings Inc (SBC) and UNITY BANCORP INC (UNTY). Click either name above to swap in a different company.
SBC Medical Group Holdings Inc is the larger business by last-quarter revenue ($39.6M vs $35.3M, roughly 1.1× UNITY BANCORP INC). UNITY BANCORP INC runs the higher net margin — 43.9% vs 35.9%, a 8.0% gap on every dollar of revenue. On growth, UNITY BANCORP INC posted the faster year-over-year revenue change (24.2% vs -10.9%). SBC Medical Group Holdings Inc produced more free cash flow last quarter ($51.2M vs $44.3M). Over the past eight quarters, UNITY BANCORP INC's revenue compounded faster (17.5% CAGR vs -15.0%).
SBC Medical Group Holdings Inc. is a leading Japan-headquartered healthcare provider primarily focused on aesthetic medicine, dermatology, and anti-aging wellness services. It operates an extensive network of clinics across Japan, catering to both domestic patients and international medical tourists, with core offerings including cosmetic surgery and non-invasive skincare treatments.
Unity Bancorp Inc is a New Jersey-headquartered financial holding company operating Unity Bank. It offers a full range of commercial and retail banking services including business loans, deposit products, mortgage services, and personal banking solutions, primarily serving small and medium-sized enterprises and individual consumers across local communities in New Jersey and eastern Pennsylvania.
SBC vs UNTY — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $39.6M | $35.3M |
| Net Profit | $14.2M | $15.5M |
| Gross Margin | 73.1% | — |
| Operating Margin | 32.5% | 55.8% |
| Net Margin | 35.9% | 43.9% |
| Revenue YoY | -10.9% | 24.2% |
| Net Profit YoY | 117.2% | 34.5% |
| EPS (diluted) | $0.15 | $1.52 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $39.6M | $35.3M | ||
| Q3 25 | $43.4M | $32.8M | ||
| Q2 25 | $43.4M | $34.4M | ||
| Q1 25 | $47.3M | $29.4M | ||
| Q4 24 | $44.4M | $28.4M | ||
| Q3 24 | $53.1M | $27.7M | ||
| Q2 24 | $53.1M | $25.5M | ||
| Q1 24 | $54.8M | $25.6M |
| Q4 25 | $14.2M | $15.5M | ||
| Q3 25 | $12.8M | $14.4M | ||
| Q2 25 | $2.5M | $16.5M | ||
| Q1 25 | $21.5M | $11.6M | ||
| Q4 24 | $6.5M | $11.5M | ||
| Q3 24 | $2.8M | $10.9M | ||
| Q2 24 | $18.5M | $9.5M | ||
| Q1 24 | $18.8M | $9.6M |
| Q4 25 | 73.1% | — | ||
| Q3 25 | 70.6% | — | ||
| Q2 25 | 69.2% | — | ||
| Q1 25 | 79.7% | — | ||
| Q4 24 | 76.3% | — | ||
| Q3 24 | 81.5% | — | ||
| Q2 24 | 74.2% | — | ||
| Q1 24 | 72.1% | — |
| Q4 25 | 32.5% | 55.8% | ||
| Q3 25 | 36.6% | 57.5% | ||
| Q2 25 | 33.6% | 62.6% | ||
| Q1 25 | 51.1% | 52.6% | ||
| Q4 24 | 10.6% | 51.0% | ||
| Q3 24 | 26.1% | 52.7% | ||
| Q2 24 | 51.4% | 49.3% | ||
| Q1 24 | 44.6% | 50.0% |
| Q4 25 | 35.9% | 43.9% | ||
| Q3 25 | 29.6% | 43.8% | ||
| Q2 25 | 5.7% | 48.0% | ||
| Q1 25 | 45.4% | 39.5% | ||
| Q4 24 | 14.7% | 40.5% | ||
| Q3 24 | 5.3% | 39.4% | ||
| Q2 24 | 34.8% | 37.1% | ||
| Q1 24 | 34.2% | 37.5% |
| Q4 25 | $0.15 | $1.52 | ||
| Q3 25 | $0.12 | $1.41 | ||
| Q2 25 | $0.02 | $1.61 | ||
| Q1 25 | $0.21 | $1.13 | ||
| Q4 24 | $0.05 | $1.13 | ||
| Q3 24 | $0.03 | $1.07 | ||
| Q2 24 | $0.20 | $0.92 | ||
| Q1 24 | $0.20 | $0.94 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $164.1M | — |
| Total DebtLower is stronger | $42.8M | — |
| Stockholders' EquityBook value | $248.3M | $345.6M |
| Total Assets | $380.4M | $3.0B |
| Debt / EquityLower = less leverage | 0.17× | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $164.1M | — | ||
| Q3 25 | $127.4M | — | ||
| Q2 25 | $152.7M | — | ||
| Q1 25 | $132.1M | — | ||
| Q4 24 | $125.0M | — | ||
| Q3 24 | $137.4M | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | $42.8M | — | ||
| Q3 25 | $21.1M | — | ||
| Q2 25 | $7.1M | — | ||
| Q1 25 | $6.9M | — | ||
| Q4 24 | $6.6M | $230.8M | ||
| Q3 24 | $823.2K | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | $248.3M | $345.6M | ||
| Q3 25 | $248.0M | $334.0M | ||
| Q2 25 | $244.6M | $319.8M | ||
| Q1 25 | $226.4M | $306.1M | ||
| Q4 24 | $195.1M | $295.6M | ||
| Q3 24 | $205.0M | $284.3M | ||
| Q2 24 | $8.8M | $273.4M | ||
| Q1 24 | $9.0M | $266.8M |
| Q4 25 | $380.4M | $3.0B | ||
| Q3 25 | $321.4M | $2.9B | ||
| Q2 25 | $315.3M | $2.9B | ||
| Q1 25 | $284.6M | $2.8B | ||
| Q4 24 | $266.1M | $2.7B | ||
| Q3 24 | $296.5M | $2.6B | ||
| Q2 24 | $19.5M | $2.6B | ||
| Q1 24 | $19.8M | $2.6B |
| Q4 25 | 0.17× | — | ||
| Q3 25 | 0.09× | — | ||
| Q2 25 | 0.03× | — | ||
| Q1 25 | 0.03× | — | ||
| Q4 24 | 0.03× | 0.78× | ||
| Q3 24 | 0.00× | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $52.0M | $44.9M |
| Free Cash FlowOCF − Capex | $51.2M | $44.3M |
| FCF MarginFCF / Revenue | 129.3% | 125.7% |
| Capex IntensityCapex / Revenue | 2.0% | 1.6% |
| Cash ConversionOCF / Net Profit | 3.66× | 2.90× |
| TTM Free Cash FlowTrailing 4 quarters | $23.3M | $81.7M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $52.0M | $44.9M | ||
| Q3 25 | $-20.9M | $45.5M | ||
| Q2 25 | $-8.3M | $-25.3M | ||
| Q1 25 | $1.9M | $17.9M | ||
| Q4 24 | $-7.3M | $48.0M | ||
| Q3 24 | $5.0M | $17.7M | ||
| Q2 24 | $19.2M | $-8.4M | ||
| Q1 24 | $3.7M | $15.8M |
| Q4 25 | $51.2M | $44.3M | ||
| Q3 25 | $-20.9M | $45.3M | ||
| Q2 25 | $-8.6M | $-25.5M | ||
| Q1 25 | $1.7M | $17.6M | ||
| Q4 24 | $-7.9M | $47.3M | ||
| Q3 24 | $4.6M | $17.5M | ||
| Q2 24 | $18.3M | $-8.6M | ||
| Q1 24 | $3.0M | $15.7M |
| Q4 25 | 129.3% | 125.7% | ||
| Q3 25 | -48.3% | 138.1% | ||
| Q2 25 | -19.9% | -74.2% | ||
| Q1 25 | 3.5% | 59.9% | ||
| Q4 24 | -17.8% | 166.5% | ||
| Q3 24 | 8.7% | 63.3% | ||
| Q2 24 | 34.5% | -33.7% | ||
| Q1 24 | 5.4% | 61.4% |
| Q4 25 | 2.0% | 1.6% | ||
| Q3 25 | 0.1% | 0.7% | ||
| Q2 25 | 0.7% | 0.5% | ||
| Q1 25 | 0.5% | 1.0% | ||
| Q4 24 | 1.3% | 2.4% | ||
| Q3 24 | 0.8% | 0.5% | ||
| Q2 24 | 1.6% | 0.5% | ||
| Q1 24 | 1.3% | 0.3% |
| Q4 25 | 3.66× | 2.90× | ||
| Q3 25 | -1.63× | 3.16× | ||
| Q2 25 | -3.39× | -1.54× | ||
| Q1 25 | 0.09× | 1.54× | ||
| Q4 24 | -1.12× | 4.17× | ||
| Q3 24 | 1.77× | 1.62× | ||
| Q2 24 | 1.04× | -0.89× | ||
| Q1 24 | 0.20× | 1.64× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
SBC
| Franchising | $10.3M | 26% |
| Medical Corporation Shobikai | $8.1M | 21% |
| Medical Corporation Nasukai | $7.2M | 18% |
| Management Services | $6.3M | 16% |
| Rental Services | $4.3M | 11% |
| Medical Corporation Association Furinkai | $3.0M | 8% |
| Japan Medical And Beauty Inc | $656.5K | 2% |
UNTY
Segment breakdown not available.
